Back to Screener

Avalon GloboCare Corp. Common Stock (ALBT)

Price$0.36
Value ScoreC
Growth ScoreD
Momentum ScoreF

Favorite Metrics

Price vs S&P 500 (26W)-83.80%
Price vs S&P 500 (4W)-10.72%
VGM Score34.18
Market Capitalization$4.30M

All Metrics

Book Value / Share (Quarterly)$1.41
P/TBV (Annual)0.77x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-1.38%
Cash Flow / Share (Quarterly)$-0.76
Price vs S&P 500 (YTD)-78.40%
Gross Margin (TTM)25.70%
Net Profit Margin (TTM)-1355.20%
EPS (TTM)$-8.23
10-Day Avg Trading Volume0.21M
EPS Excl Extra (TTM)$-8.23
Revenue Growth (5Y)-2.97%
EPS (Annual)$-8.44
ROI (Annual)-52.93%
Gross Margin (Annual)15.41%
Net Profit Margin (5Y Avg)-898.04%
Cash / Share (Quarterly)$0.09
Revenue Growth QoQ (YoY)1.43%
ROA (Last FY)-37.66%
Revenue Growth TTM (YoY)6.66%
EBITD / Share (TTM)$-5.17
ROE (5Y Avg)-209.56%
Operating Margin (TTM)-1217.46%
Cash Flow / Share (Annual)$-1.03
P/B Ratio0.37x
P/B Ratio (Quarterly)0.38x
Net Income / Employee (Annual)$-3,951,700
EV / Revenue (TTM)3.43x
Net Interest Coverage (TTM)-1.72x
ROA (TTM)-142.87%
EPS Incl Extra (Annual)$-8.44
Current Ratio (Annual)0.11x
Quick Ratio (Quarterly)0.29x
3-Month Avg Trading Volume5.06M
52-Week Price Return-89.54%
Revenue / Employee (TTM)$698,000
Tangible BV / Share (Quarterly)$1.21
P/S Ratio (Annual)3.23x
Asset Turnover (Annual)0.06x
52-Week High$4.74
Operating Margin (5Y Avg)-787.76%
EPS Excl Extra (Annual)$-8.44
Tangible BV CAGR (5Y)12.07%
26-Week Price Return-75.87%
Quick Ratio (Annual)0.09x
13-Week Price Return-58.81%
Total Debt / Equity (Annual)0.10x
Current Ratio (Quarterly)0.38x
Enterprise Value$4.78M
Revenue / Share Growth (5Y)133.29%
Asset Turnover (TTM)0.11x
Book Value / Share Growth (5Y)-0.05%
Revenue / Employee (Annual)$666,700
Pretax Margin (Annual)-592.72%
Cash / Share (Annual)$0.02
3-Month Return Std Dev103.46%
Gross Margin (5Y Avg)22.93%
Net Income / Employee (TTM)$-9,130,500
ROE (Last FY)-111.27%
Net Interest Coverage (Annual)-9.71x
EPS Basic Excl Extra (Annual)$-8.44
Receivables Turnover (TTM)16.92x
Total Debt / Equity (Quarterly)0.11x
EPS Incl Extra (TTM)$-8.23
Receivables Turnover (Annual)9.58x
ROI (TTM)-20.33%
P/S Ratio (TTM)3.08x
Pretax Margin (5Y Avg)-898.04%
Revenue / Share (Annual)$1.42
Tangible BV / Share (Annual)$1.46
Price vs S&P 500 (52W)-113.91%
Year-to-Date Return-70.24%
5-Day Price Return3.81%
EPS Normalized (Annual)$-8.44
ROA (5Y Avg)-78.06%
Net Profit Margin (Annual)-592.72%
Month-to-Date Return0.03%
Cash Flow / Share (TTM)$-0.90
EBITD / Share (Annual)$-6.16
Operating Margin (Annual)-432.47%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-109.11%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-8.23
P/TBV (Quarterly)0.44x
P/B Ratio (Annual)0.59x
Inventory Turnover (TTM)78.67x
Pretax Margin (TTM)-1355.20%
Book Value / Share (Annual)$1.90
Price vs S&P 500 (13W)-67.07%
Beta-0.07x
Revenue / Share (TTM)$0.34
ROE (TTM)-22.38%
52-Week Low$0.21
vGradeC
gGradeD
mGradeF
vgmGradeD
Show chart for

Earnings Surprise History

Q1 26-0.49est.

Industry Peers — Computer Programming(43)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
ALBTAvalon GloboCare Corp. Common Stock
CDF$0.36
INFYInfosys Limited American Depositary SharesCCC$12.40
VRSNVeriSign IncDCB$294.92
CTSHCognizant Technology SolutionsBDD$53.21
WITWipro LimitedCDB$2.10
ZSZscaler, Inc. Common StockDAD$130.78
RGTIRigetti Computing, Inc. Common StockFCB$20.68
DOXAmdocs LimitedBDC$60.09
FORTYFormula Systems 1985 LtdBCB$126.00
EPAMEPAM SYSTEMS, INC.BCD$98.04
DOCSDoximity, Inc.CCD$20.59

About

Avalon Globocare Corp operates two primary segments: real property management, which is the primary revenue source, and laboratory testing services. The company develops diagnostic and therapeutic biotechnology solutions targeting early detection and treatment of cancers, including oral, ovarian, and kidney variants, as well as skin regeneration, anti-fibrosis, and degenerative disorder applications.